Skip to main content
Clinical Trials/JPRN-UMIN000003564
JPRN-UMIN000003564
Recruiting
Phase 3

Randomized controlled trial of percutaneous osteoplasty in patients with painful malignant bone tumor (JIVROSG-0804) - Randomized controlled trial of osteoplasty

Japan Interventional Radiology in Oncology Study Group (JIVROSG)0 sites18 target enrollmentMay 5, 2010

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Malignant bone tumor
Sponsor
Japan Interventional Radiology in Oncology Study Group (JIVROSG)
Enrollment
18
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 5, 2010
End Date
October 31, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Japan Interventional Radiology in Oncology Study Group (JIVROSG)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Cardiac failure requiring medical therapy 2\. Extensive bone destruction in posterior aspect of vertebral bodies or compression of spinal cord by the tumor 4\. Bone destruction in acetabulum 5\. Uncontrollable bleeding tendency 6\. History of advanced drug allergy 7\. Active infectious disease 8\. Active inflammatory process in intended bone 9\. Under radiotherapy for the bone tumor or less than 4 weeks after the completion of RTx without progression of the symptom 10\. Indication for strontium\-89 radiotherapy 11\. Difficulty of keeping treatment position for one hour with medical or physical treatments 12\. Incapable in dose escalation of analgesics 13\. Pregnancy 14\. Contraindication decided by attending physician

Outcomes

Primary Outcomes

Not specified

Similar Trials